Comparison of Cerebraca Wafer Plus Temozolomide Versus Temozolomide Alone in Recurrent Glioblastoma

NCT07349693 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

175

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent Glioblastoma, IDH-Wildtype

Interventions

DRUG: Cerebraca wafer
DRUG: Temozolomide (for relapsed malignant glioma)

Sponsor

Everfront Biotech Co., Ltd.